SCHEMBL2015729

SCHEMBL2015729

CCCCOC(=O)NC(C(=O)O)c1ccsc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.44
RAB9A P51151 7/20 0.44
NPC1 O15118 6/20 0.44
HPGD P15428 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 3/20 0.43
ATM Q13315 1/20 0.43
LMNA P02545 2/20 0.41
CTSK P43235 2/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CASP1 P29466 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
MCL1 Q07820 1/20 0.39
TSHR P16473 2/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5504022 0.82 SMN1; SMN2 (0.42) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL1461981 0.82 ATM (0.60) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL11491274 0.82 ATM (0.60) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL6716729 0.81 PGR (0.45) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL14842674 0.81 ATM (0.41) ATMCTSKCHRNB2CHRNB4CHRNA3
SCHEMBL2709731 0.81 ATM (0.41) ATMCTSKCHRNB2CHRNB4CHRNA3
SCHEMBL1553456 0.80 FOLH1 (0.51) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL2014296 0.80 NPC1 (0.51) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL4685821 0.79 ATM (0.63) SMN1; SMN2RAB9ANPC1HPGDL3MBTL1
SCHEMBL11614466 0.78 ATM (0.72) RAB9AATMCTSKALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2326623-A2 BETA-AND GAMMA-AMINO-ISOQUINOLINE AMIDE COMPOUNDS AND SUBSTITUTED BENZAMIDE COMPOUNDS Aerie Pharmaceuticals, Inc. (US) 2011-06-01 EP disclosed
WO-2010011853-A2 BETA-AND GAMMA-AMINO-ISOQUINOLINE AMIDE COMPOUNDS AND SUBSTITUTED BENZAMIDE COMPOUNDS AERIE PHARMACEUTICALS, INC. (US) 2010-01-28 WO disclosed
EP-1989186-A1 HYDANTOIN BASED KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2008-11-12 EP disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed
WO-2007096259-A1 HYDANTOIN BASED KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-30 WO disclosed